Clareon
Payments companies reported to CMS as associated with Clareon. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Clareon, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Clareon
These are the largest totals companies reported as associated with Clareon. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Micheletti | Houston, TX | Ophthalmology | $311,075.60 |
| Kerry Solomon | Mt Pleasant, SC | Ophthalmology | $175,558.48 |
| Preeya Gupta | Raleigh, NC | Ophthalmology | $156,257.35 |
| William Maxwell | Fresno, CA | Ophthalmology | $118,601.20 |
| Brian Shafer | Plymouth Meeting, PA | Cornea and External Diseases Specialist | $116,346.71 |
| Robert Melendez | Albuquerque, NM | Ophthalmology | $87,642.18 |
| Warren Hill | Mesa, AZ | Ophthalmology | $78,640.66 |
| Neel Desai | Largo, FL | Ophthalmology | $77,202.66 |
| Iqbal Ahmed | Salt Lake City, UT | Ophthalmology | $69,647.10 |
| Dagny Luong | Hemet, CA | Ophthalmology | $66,109.32 |
Prescribed Clareon?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.